Literature DB >> 24846301

Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma.

Xuyong Wei1, Jie Li1, Haiyang Xie1, Qi Ling2, Jianguo Wang1, Di Lu1, Lin Zhou1, Xiao Xu3, Shusen Zheng4.   

Abstract

The present work aimed to investigate the expression and role of aminoacylase 1 (ACY1) in hepatocellular carcinoma (HCC) based on a proteomic study. The study results revealed that the expression of ACY1 was much lower in HCC tissues. ACY1 expression significantly correlated with the serum alpha fetoprotein level and tumor invasiveness. The knockdown of ACY1 in SMMC7721 cells promoted cell viability and invasiveness. In contrast, the restoration of ACY1 in BEL7402 cells inhibited cell viability and invasiveness. Further studies indicated that the knockdown of ACY1 increased the protein expression of transforming growth factor beta 1 and extracellular signal-regulated kinase 1 expression. The study's results indicated that ACY1 acts as a tumor suppressor in HCC.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aminoacylase 1; Hepatocellular carcinoma; Proteomic; Tumor suppressor

Mesh:

Substances:

Year:  2014        PMID: 24846301     DOI: 10.1016/j.canlet.2014.05.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Expanding the phenotype in aminoacylase 1 (ACY1) deficiency: characterization of the molecular defect in a 63-year-old woman with generalized dystonia.

Authors:  Jörn Oliver Sass; Jathana Vaithilingam; Corinne Gemperle-Britschgi; Cathérine C S Delnooz; Leo A J Kluijtmans; Bart P C van de Warrenburg; Ron A Wevers
Journal:  Metab Brain Dis       Date:  2015-12-19       Impact factor: 3.584

2.  Study of the expression and function of ACY1 in patients with colorectal cancer.

Authors:  Bing Yu; Xuezhong Liu; Xiuzhen Cao; Mingyue Zhang; Hong Chang
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

3.  Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure.

Authors:  Qiong Lai; Fu-Ming Liu; Wang-Lin Rao; Guang-Ying Yuan; Zhao-Yang Fan; Lu Zhang; Fei Fu; Jun-Ping Kou; Bo-Yang Yu; Fang Li
Journal:  Acta Pharmacol Sin       Date:  2021-12-16       Impact factor: 7.169

4.  ACY1 regulating PTEN/PI3K/AKT signaling in the promotion of non-small cell lung cancer progression.

Authors:  Hong Chen; Wei Wang; Caizhi Xiao; Dongqin Xia; Fangfei Li; Shaoyong Liu
Journal:  Ann Transl Med       Date:  2021-09

5.  CLIC1 Drives Angiogenesis in Hepatocellular Carcinoma by Modulating VEGFA.

Authors:  Xuyong Wei; Binhua Pan; Mengfan Yang; Wenzhi Shu; Abdul Rehman Khan; Renyi Su; Hanchao Lin; Xiao Xu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

6.  Z-Guggulsterone Is a Potential Lead Molecule of Dawa-ul-Kurkum against Hepatocellular Carcinoma.

Authors:  Meenakshi Gupta; Shaikh Maryam Ghufran; Tasneem Kausar; Rafat Ali; Subhrajit Biswas; Shahid M Nayeem; Romana Ishrat; Sher Ali; Ajaz Ahmad; Irfan A Rather; Maryam Sarwat
Journal:  Molecules       Date:  2022-08-11       Impact factor: 4.927

7.  Aminoacylase 1 (ACY-1) Mediates the Proliferation and Migration of Neuroblastoma Cells in Humans Through the ERK/Transforming Growth Factor β (TGF-β) Signaling Pathways.

Authors:  Zimin Chen; Jiahui Gao; Jun Sun; Zhouguang Wu; Bin Wang
Journal:  Med Sci Monit       Date:  2021-02-23

8.  Effect of the ACY-1 gene on HER2 and TRAIL expression in rectal carcinoma.

Authors:  Zizhong Xu; Yating Hu; Zhaohui Yu
Journal:  Exp Ther Med       Date:  2021-06-02       Impact factor: 2.447

9.  Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients.

Authors:  Giuliana Cavalloni; Caterina Peraldo-Neia; Annamaria Massa; Carlo Bergamini; Alessandro Trentini; Giovanni De Rosa; Lorenzo Daniele; Fabiola Ciccosanti; Carlo Cervellati; Francesco Leone; Massimo Aglietta
Journal:  BMC Cancer       Date:  2021-07-28       Impact factor: 4.430

10.  Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B.

Authors:  Saiping Qi; Jing Li; Xiaomin He; Jialing Zhou; Zhibin Chen; Xiaojin Li; Bei Zhang; Hong Ma; Hong You; Jian Huang
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.